长期口服小剂量胺碘酮致严重肝损伤1例并文献复习
Severe Liver Injury Caused By Long-Term Oral Low-Dose Amiodarone: A Case Report and Literature Review
DOI: 10.12677/acrvm.2024.121001, PDF,   
作者: 吴连辉：华北理工大学研究生院，河北 唐山；威县人民医院，河北 邢台；李 杰*：河北省人民医院血液内科，河北 石家庄
关键词: 药物性肝损伤；口服胺碘酮；Drug-Induced Liver Injury； Oral Amiodarone
摘要: 胺碘酮是常用的广谱抗心律失常药物，广泛用于治疗和预防多种心律失常性疾病。长期口服胺碘酮可引起心动过缓、甲状腺功能异常、肺毒性、血管异常、胃肠道反应等副作用，而肝毒性相对少见，仅有不到1%的患者出现明显的肝毒性，重度肝损伤更是罕见。现报道1例长期口服小剂量胺碘酮引起的重度肝损伤，讨论病因临床特点、治疗及预后，为口服胺碘酮用药安全提供参考。
Abstract: Amiodarone is a common broad-spectrum antiarrhythmic drug, which is widely used to treat and prevent a variety of arrhythmia diseases. Long-term oral amiodarone can cause bradycardia, thyroid dysfunction, pulmonary toxicity, vascular abnormalities, gastrointestinal reactions and other side effects, while hepatotoxicity is relatively rare, with less than 1% of patients showing obvious hepatotoxicity, and severe liver injury is even rarer. This paper reports a case of severe liver injury caused by long-term oral low-dose amiodarone, and discusses the etiology, clinical characteristics, treatment and prognosis, so as to provide reference for the safety of oral amiodarone.
文章引用：吴连辉, 李杰. 长期口服小剂量胺碘酮致严重肝损伤1例并文献复习[J]. 亚洲心脑血管病例研究, 2024, 12(1): 1-5. https://doi.org/10.12677/acrvm.2024.121001

参考文献

[1] 马世武, 刘成海, 刘晓琰, 等. 中国药物性肝损伤诊治指南(2023年版) [J]. 胃肠病学, 2022, 27(6): 341-375.
[2] 于乐成, 范晔. RUCAM诊断药物性肝损伤的进展及其与结构化专家观点评估法的比较[J]. 临床肝胆病杂志, 2016, 32(9): 1706-1713.
[3] Brien, J.F., Jimmo, S., Brennan, F.J., Ford, S.E. and Armstrong, P.W. (1987) Distribution of Amiodarone and Its Metabolite, Desethylamiodarone, in Human Tissues. Canadian Journal of Physiology and Pharmacology, 65, 360-364. [Google Scholar] [CrossRef] [PubMed]
[4] Oikawa, H. (2005) Liver Cirrhosis Induced by Long-Term Administration of a Daily Low Dose of Amiodarone: A Case Report. World Journal of Gastroenterology, 11, 5394-5397. [Google Scholar] [CrossRef] [PubMed]
[5] Waldhauser, K.M., Török, M., Ha, H., Thomet, U., Konrad, D., Brecht, K., et al. (2006) Hepatocellular Toxicity and Pharmacological Effect of Amiodarone and Amiodarone Derivatives. Journal of Pharmacology and Experimental Therapeutics, 319, 1413-1423. [Google Scholar] [CrossRef] [PubMed]
[6] Pollak, P. (2000) Population Pharmacokinetics of Long-Term Oral Amiodarone Therapy. Clinical Pharmacology & Therapeutics, 67, 642-652. [Google Scholar] [CrossRef] [PubMed]
[7] Buggey, J., Kappus, M., Lagoo, A.S. and Brady, C.W. (2015) Amiodarone-Induced Liver Injury and Cirrhosis. ACG Case Reports Journal, 2, 116-118. [Google Scholar] [CrossRef] [PubMed]
[8] Nagata, T., Takata, K., Shakado, S. and Hirai, F. (2023) Amiodarone-Induced Hepatotoxicity. BMJ Case Reports, 16, e256679. [Google Scholar] [CrossRef] [PubMed]
[9] 常柳祎, 祖秀宏, 栾中华, 等. 长期服用胺碘酮致肝脏不良结局[J]. 药物不良反应杂志, 2023, 25(2): 117-120.
[10] National Institute of Diabetes and Digestive and Kidney Diseases (2012) LiverTox: Clinical and Research Information on Drug-Induced Liver Injury.
[11] Tsuda, T., Tada, H., Tanaka, Y., Nishida, N., Yoshida, T., Sawada, T., et al. (2018) Amiodarone-Induced Reversible and Irreversible Hepatotoxicity: Two Case Reports. Journal of Medical Case Reports, 12, Article No. 95. [Google Scholar] [CrossRef] [PubMed]
[12] Wu, I.U., Tsai, J. and Ho, C. (2021) Fatal Acute-On-Chronic Liver Failure in Amiodarone-Related Steatohepatitis: A Case Report. BMC Gastroenterology, 21, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[13] Sung, P.S. and Yoon, S.K. (2011) Amiodarone Hepatotoxicity. Hepatology, 55, 325-326. [Google Scholar] [CrossRef] [PubMed]
[14] Chang, C., Petrelli, M., Tomashefski, J.F. and McCullough, A.J. (1999) Severe Intrahepatic Cholestasis Caused by Amiodarone Toxicity after Withdrawal of the Drug. Archives of Pathology & Laboratory Medicine, 123, 251-256. [Google Scholar] [CrossRef] [PubMed]
[15] Keng, L. and Liao, M. (2018) Amiodarone-Induced Hepatic and Pulmonary Toxicity. Postgraduate Medical Journal, 94, 603-603. [Google Scholar] [CrossRef] [PubMed]
[16] Kang, H.M., Kang, Y.S., Kim, S.H., Seong, J.K., Kang, D.Y., Lee, H.Y., et al. (2007) Amiodarone-Induced Hepatitis and Polyneuropathy. The Korean Journal of Internal Medicine, 22, 225-229. [Google Scholar] [CrossRef] [PubMed]
[17] Raja, K., Thung, S., Fiel, M.I. and Chang, C. (2009) Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use. Seminars in Liver Disease, 29, 423-428. [Google Scholar] [CrossRef] [PubMed]
[18] Salti, Z., Cloche, P., Weber, P., et al. (1989) A Case of Cholestatic Hepatitis Caused by Amiodarone. Annales de Cardiologie et d’Angéiologie, 38, 13-16.

为你推荐